| IMMUNIC, INC. | IMUX | BVF PARTNERS L P/ILDirDERIVJOINT | Sep 16 | A | 25,370 | $0.00 | —? |
| XOMA Royalty Corp | XOMA | BVF PARTNERS L P/IL10%JOINT | Jul 14 | U | 772,000 | — | — |
| XOMA Royalty Corp | XOMA | BVF PARTNERS L P/IL10%JOINT | Jul 14 | U | 412,000 | — | — |
| XOMA Royalty Corp | XOMA | BVF PARTNERS L P/IL10%JOINT | Jul 14 | U | 2,773,545 | — | — |
| XOMA Royalty Corp | XOMA | BVF PARTNERS L P/IL10%JOINT | Jul 14 | U | 3,635,758 | — | — |
| Kymera Therapeutics, Inc. | KYMR | BVF PARTNERS L P/ILDirJOINT | Jun 26 | S | 51,858 | $106.50 | $5.5M |
| Kymera Therapeutics, Inc. | KYMR | BVF PARTNERS L P/ILDirJOINT | Jun 26 | S | 113,289 | $106.50 | $12.1M |
| Kymera Therapeutics, Inc. | KYMR | BVF PARTNERS L P/ILDirJOINT | Jun 26 | S | 627,597 | $106.50 | $66.8M |
| Kymera Therapeutics, Inc. | KYMR | BVF PARTNERS L P/ILDirJOINT | Jun 26 | S | 837,914 | $106.50 | $89.2M |
| Kymera Therapeutics, Inc. | KYMR | BVF PARTNERS L P/ILDirDERIVJOINT | Jun 24 | A | 6,068 | $0.00 | —? |
| Olema Pharmaceuticals, Inc. | OLMA | BVF PARTNERS L P/ILDirDERIVJOINT | Jun 18 | A | 29,500 | $0.00 | —? |
| MoonLake Immunotherapeutics | MLTX | BVF PARTNERS L P/ILDirDERIVJOINT | Jun 17 | A | 22,195 | $0.00 | —? |
| XOMA Royalty Corp | XOMA | BVF PARTNERS L P/IL10%DERIVJOINT | May 14 | C | 772 | $0.00 | —? |
| XOMA Royalty Corp | XOMA | BVF PARTNERS L P/IL10%DERIVJOINT | May 14 | C | 412 | $0.00 | —? |
| XOMA Royalty Corp | XOMA | BVF PARTNERS L P/IL10%DERIVJOINT | May 14 | C | 1,506 | $0.00 | —? |
| XOMA Royalty Corp | XOMA | BVF PARTNERS L P/IL10%DERIVJOINT | May 14 | C | 2,313 | $0.00 | —? |
| XOMA Royalty Corp | XOMA | BVF PARTNERS L P/IL10%JOINT | May 14 | C | 772,000 | $4.03 | $3.1M |
| XOMA Royalty Corp | XOMA | BVF PARTNERS L P/IL10%JOINT | May 14 | C | 412,000 | $4.03 | $1.7M |
| XOMA Royalty Corp | XOMA | BVF PARTNERS L P/IL10%JOINT | May 14 | C | 1,506,000 | $4.03 | $6.1M |
| XOMA Royalty Corp | XOMA | BVF PARTNERS L P/IL10%JOINT | May 14 | C | 2,313,000 | $4.03 | $9.3M |
| MoonLake Immunotherapeutics | MLTX | BVF PARTNERS L P/ILDirJOINT | Mar 31 | S | 248,530 | $16.79 | $4.2M |
| MoonLake Immunotherapeutics | MLTX | BVF PARTNERS L P/ILDirJOINT | Mar 31 | S | 1,569,116 | $16.79 | $26.3M |
| MoonLake Immunotherapeutics | MLTX | BVF PARTNERS L P/ILDirJOINT | Mar 31 | S | 1,932,354 | $16.79 | $32.4M |
| Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P/IL10%JOINT | Jan 28 | U | 548,938 | — | — |
| Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P/IL10%JOINT | Jan 28 | U | 4,308,573 | — | — |
| Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P/IL10%JOINT | Jan 28 | U | 5,309,432 | — | — |
| ESSA Pharma Inc. | EPIX | BVF PARTNERS L P/IL10%JOINT | Oct 9 | U | 560,797 | — | — |
| ESSA Pharma Inc. | EPIX | BVF PARTNERS L P/IL10%JOINT | Oct 9 | U | 4,726,743 | — | — |
| ESSA Pharma Inc. | EPIX | BVF PARTNERS L P/IL10%JOINT | Oct 9 | U | 6,194,145 | — | — |